Clinical Trials | April 22, 2026
Asahi Kasei pushes into human trials with new autoimmune drug candidate
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
It is actually a new ISO Class 5 controlled cleanroom designed to deliver washed, dried, and gamma-sterilized single-use assemblies ready for immediate use.
Targets high-growth eye care expansion push
The plant is currently scaling towards a production capacity of nearly 3 million gloves per day
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
The approval, following a positive recommendation from the European Medicines Agency’s CHMP, makes the vaccine valid across all 27 EU member states
The cleanroom operates under stringent ISO Class 5 conditions, using ultrapure water and air systems
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
This includes 14.3 million views on YouTube and 9.8 million views on Meta platforms to amplify preventive heart health message
Subscribe To Our Newsletter & Stay Updated
